B.1.1.529 variant named Omicron, designated as a Variant of concern (VOC) by WHO

WHO’s Technical Advisory Group on SARS-CoV-2 Virus Evolution (TAG-VE) was convened on 26th November 2021 to assess the variant B.1.1.529. Based on the available evidences, the group of experts has advised WHO that this variant should be designated as a Variant of concern (VOC), and named Omicron. 

The B.1.1.529 variant was first reported to WHO from South Africa on 24th November 2021. The first known confirmed B.1.1.529 infection was from a specimen collected on 9th November 2021. Since then, the number of COVID-19 cases has steeply increased in almost all provinces in South Africa. This variant is characterised by a large number of mutations. Apparently, there is an increased risk of reinfection with this variant, as compared to others.  

Hence, based on the available evidences, the expert group has advised WHO that this variant should be designated as a VOC, and named Omicron. 

A variant of concern (VOC) is a variant of interest (VOI) that has shown an increase in transmissibility and/or virulence and/or decrease in effectiveness of public health measures at a degree of global public health significance: 

Individuals are reminded to take appropriate COVID-19 measures to reduce their risk of disease, including proven public health and social measures such as wearing well-fitting masks, hand hygiene, physical distancing, improving ventilation of indoor spaces, avoiding crowded spaces, and getting vaccinated. 

 *** 

Source:  

WHO 2021. News – Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern. Published 26 November 2021. Available online at https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern  

Latest

Daraxonrasib Approved for Pancreatic Cancer

Daraxonrasib (Rasonque by Revolution Medicines, Inc.), an inhibitor of...

Glacial Collapse Led to Seismic Event in Nepal 

The magnitude 5.2 seismic event recorded near the border...

Significance of Nancy Grace Roman Space Telescope

Nancy Grace Roman Space Telescope (commonly referred to as...

NASA Invites ISRO to Join Moon Base Programme

NASA has invited ISRO (Indian Space Research Organisation) to...

2026 Total Solar Eclipse

On 12 August 2026, a total solar eclipse was...

AI Designs Complete Functional Genomes

The genome language model Evo 2 has designed novel...

Newsletter

Don't miss

Irish Research Council Takes Several Initiatives to Support Research

Irish government announces €5 million in funding to support...

Brain-Computer Interfaces (BCI): Towards Humans’ Merger with AI 

The ongoing clinical trials of Brain-Computer Interfaces (BCIs) such...

Chinchorro Culture: Mankind’s Oldest Artificial Mummification

The oldest evidence of artificial mummification in the world comes...

Climate Effects of Atmospheric Mineral Dust: EMIT Mission Achieves Milestone  

With its first view of Earth, NASA’s EMIT Mission...

Nuclear Sites In Iran: Some Localized Radioactive Release 

As per agency’s assessment, there has been some localized...

FDA approves Tecelra (a T cell receptor gene therapy) for Synovial Sarcoma 

Tecelra (afamitresgene autoleucel), a gene therapy for the treatment...
SCIEU Team
SCIEU Teamhttps://www.scientificeuropean.co.uk
Scientific European® | SCIEU.com | Significant advances in science. Impact on humankind. Inspiring minds.

Daraxonrasib Approved for Pancreatic Cancer

Daraxonrasib (Rasonque by Revolution Medicines, Inc.), an inhibitor of the RAS GTPase family has been approved for the treatment of adults with metastatic pancreatic...

Glacial Collapse Led to Seismic Event in Nepal 

The magnitude 5.2 seismic event recorded near the border between Nepal and China on 26 August 2026 at 8:37 AM local time (02:52:10 UTC) has...

Significance of Nancy Grace Roman Space Telescope

Nancy Grace Roman Space Telescope (commonly referred to as Roman Telescope) is set to be launched into space on 30 August 2026. It will...